THERAPiN
Formerly Hi-Pharma
Cannabis-based Drug Preparations
Startup A Health Tech & Life Sciences Est. 2017
Total Raised
$22M
A
Last Round
$10M
2 rounds
Investors
1
Team
3
1-10 employees
Confidence
82/100
About
THERAPiN develops, grows, and produces raw materials and premium cannabis products for medical and cosmetic use for the international market.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyCosmetic MaterialsMedical Cannabis
Core Technology
BiologicalsHerbalsMaterials & SubstancesRaw Materials
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCosmeticsConsumersRecreational & LifestyleCannabis
Business Model
B2CB2B
Tags
pharmaceuticalsmedical-cannabismedical-productspatientsconsumerspharma-companieschronic-patients
Funding & Events
Dec 2019
Seed $12M
Undisclosed Investor(s)
Apr 2020
A Round $10M
Undisclosed Investor(s)
Details
Product Stage
Released
Employees
1-10
Exact Count
8
District
North District
Founded
2017
Registrar
515725000
Crunchbase
therapin
Locations
Ramot Menashe, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Oct 11, 2021
Verified by
Yanina Wainscheinker
Missing
description, news, not claimed
Team (3)
Moshe Meidar
CEO
Iftah Katz
VP Operations
Tal Gross
Grow Manager & Extaction Facility
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2018-11-29T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wain@gmail.com)